- Business
- PIOLAX, Inc. manufactures and sells precision automotive components, medical equipment, and related products worldwide; its core offerings encompass coil springs, flat springs, wire forms, metal and plastic fasteners, unit assembly parts, valves and fuel system parts including fuel cut-off valves, filler neck valves, check valves, quick connectors, evap tubes, and resin molded parts; radiator piping connectors; compact filters for fuel and oil systems; transmission springs and snap rings; air dampers, latches, and spring-loaded cushions for glove boxes where it commands the world's largest market share in air dampers and Japan's largest in glove box latches; interior and exterior fasteners such as resin nuts, metal nuts, harness clips, hose clamps including plate and screw types, hinges, retainers, and tension springs; as well as medical devices for interventional radiology, endoscopic treatments, and orthopedic applications through subsidiary PIOLAX Medical Devices Inc. Founded in September 1939 and headquartered in Hodogaya-ku, Yokohama, Japan, the company operates primarily in the automotive sector serving original equipment manufacturers in Japan, the United States, Europe, Asia, and other regions via 15 consolidated subsidiaries including PIOLAX Corporation in the U.S., PIOLAX Ltd. in the U.K., PIOLAX Co., Ltd. in South Korea, Dongguan Piolax Co., Ltd. and Wuhan Piolax Co., Ltd. in China, Piolax (Thailand) Ltd., Piolax India Private Limited, Piolax Mexicana S.A. de C.V., and PT. Piolax Indonesia. Recent developments include an April 2025 organizational restructuring from a strategic business unit system to a functional organization; an October 2025 merger with consolidated subsidiary PIOLAX Business Service Co., Ltd. and relocation of headquarters back to Hodogaya-ku, Yokohama from Nishi-ku; an April 2024 merger with P.M.T. Inc.; August 2025 notices of simplified absorption-type mergers involving consolidated subsidiaries and related splits; ongoing share buyback programs with updates in November 2025; and November 2025 financial results announcements for periods ended September 30, 2025.